van Zyl-Smit, Richard N.
Kerstjens, Huib A. M.
Maspero, Jorge
Tanase, Ana-Maria
Lawrence, David
Mezzi, Karen
D’Andrea, Peter
Chapman, Kenneth R.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Triple Therapy with Mometasone/Indacaterol/Glycopyrronium or Doubling the ICS/LABA Dose in GINA Step 4: IRIDIUM Analyses
https://doi.org/10.1007/s41030-023-00234-y
Efficacy of one time per day, single-inhaler indacaterol/glycopyrronium/mometasone in patients with inadequately controlled asthma: post hoc analysis of IRIDIUM study in Asian population
https://doi.org/10.1136/bmjresp-2020-000856
One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies
https://doi.org/10.1136/bmjresp-2020-000819
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 3 May 2023
Accepted: 23 June 2023
First Online: 1 August 2023